Literature DB >> 26581636

Real life thromboprophylaxis in orthopedic surgery in Italy. Results of the GIOTTO study.

Filippo Randelli1, Claudio Cimminiello2, Michele Capozzi3, Mario Bosco4, Giuliano Cerulli5.   

Abstract

INTRODUCTION: Data from a prospective, multicentre observational study (Studio GIOTTO) were analyzed to determine, in clinical practice, the pattern of VTE prophylaxis and adherence to international guidelines recommendations in major orthopedic surgery (MOS) - including total hip arthroplasty (THA), total knee arthroplasty (TKA) and hip fracture surgery (HFS) - and knee arthroscopic surgery (KAS).
METHODS: In 2010, the first consecutive 30 patients hospitalized in Italian centers for MOS and the first 15 for KAS were enrolled and treated according to the usual practice.
RESULTS: 2010 patients were admitted for MOS (577 TKA, 787 THA and 646 HFS) and 993 for KAS; mean ± SD age was 71.7 ± 8 and 43.0 ± 15 years, and female prevalence was 65.6% and 31.1% in MOS and KAS, respectively. Most (66.7%; 95% CI: 65-69%) patients admitted for MOS received a combined VTE prophylaxis, consisting of both pharmacological and physical tools, and 33.2% (95% CI: 31-35%) only pharmacological. For KAS figures were 23.7 (95% CI: 21-26%) and 75.3% (95% CI: 72-77%). Most MOS (91%; 95% CI: 89-92%) and KAS (95% CI: 98-100%) patients receiving pharmacological thromboprophylaxis were treated with low molecular weight heparin (LMWH), for (median) 40 days in TKR, 39 days in THR, 44 in HFS, and 16 in KAS. Patients receiving <35 days of LMWH prophylaxis among those undergoing THR and HFS were 8.9% and 5.9%, respectively.
CONCLUSION: Although most patients undergoing orthopedic surgery received VTE prophylaxis, a gap between clinical practice and international guideline recommendations was observed. The reduced adherence to guideline recommendations is relevant for certain choices like type and duration of VTE, and physicians' behavior may reflect the changing approach of guidelines in their different editions.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Heparin, low-molecular-weight; Observational study; Orthopedics; Prophylaxis; Surgical procedures, operative; Venous thromboembolism

Mesh:

Substances:

Year:  2015        PMID: 26581636     DOI: 10.1016/j.thromres.2015.11.007

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

Review 1.  Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.

Authors:  Susan R Kahn; David R Morrison; Gisèle Diendéré; Alexandre Piché; Kristian B Filion; Adi J Klil-Drori; James D Douketis; Jessica Emed; André Roussin; Vicky Tagalakis; Martin Morris; William Geerts
Journal:  Cochrane Database Syst Rev       Date:  2018-04-24

2.  Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis.

Authors:  Hai-Feng Huang; Jia-Liang Tian; Xian-Teng Yang; Li Sun; Ru-Yin Hu; Zhi-Hui Yan; Shan-Shan Li; Quan Xie; Xiao-Bin Tian
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

Review 3.  An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020.

Authors:  Daniel C Santana; Ahmed K Emara; Melissa N Orr; Alison K Klika; Carlos A Higuera; Viktor E Krebs; Robert M Molloy; Nicolas S Piuzzi
Journal:  Medicina (Kaunas)       Date:  2020-08-19       Impact factor: 2.430

4.  Knowledge and Behavior toward Venous Thromboembolism Event Prophylaxis and Treatment Protocols among Medical Interns in Riyadh.

Authors:  Zohair Al Aseri; Jumanah Meshari Muammar; Najd Fahad Aldakkan; Afnan A Alhazmi; Hadeel Hamad Albraik; Aeshah Abdullah Alasmari; Lyla Mohammed Ashry; Shaik S Ahmed; Aamer Aleem
Journal:  Biomed Res Int       Date:  2022-07-20       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.